Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Activated PI3Kdelta Syndrome (APDS); PASLI Disease”

3 trials

Showing 3 of 3 results

Large-scale testing (Phase 3)Ended earlyNCT02859727
What this trial is testing

Extension to the Study of Efficacy of CDZ173 in Patients With APDS/PASLI

Who this might be right for
Activated PI3Kdelta Syndrome (APDS); PASLI Disease
Pharming Technologies B.V. 37
Testing effectiveness (Phase 2)Study completedNCT03383380
What this trial is testing

Rapamycin Treatment for Activated Phosphoinositide 3-Kinase δ Syndrome

Who this might be right for
Activated PI3K-delta SyndromeImmunodeficiency Primary
Children's Hospital of Fudan University 30
Large-scale testing (Phase 3)Study completedNCT02435173
What this trial is testing

Study of Efficacy of CDZ173 in Patients With APDS/PASLI

Who this might be right for
Common Variable Immunodeficiency (CVID), APDS / PASLI
Novartis Pharmaceuticals 37

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation